EFFECTS OF 1-DESAMO-8-D-ARGININE VASOPRESSIN ON BEHAVIOUR AND COGNITION IN PRIMARY AFFECTIVE DISORDER
- 31 October 1979
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 314 (8150), 992-994
- https://doi.org/10.1016/s0140-6736(79)92563-7
Abstract
DDAVP (1-desamino-8-d-arginine vasopressin), a synthetic analogue of vasopressin with prolonged half-life and high antidiuretic and low pressor activity, was given in a double-blind placebo-controlled trial to four patients with major affective illness. Three of four patients showed highly significant and consistent improvements in tests designed to measure the formation, encoding, and organisation of long-term trace events in memory. Two patients also showed a significant but less consistent amelioration of other depressive symptoms during DDAVP treatment. These findings implicate central vasopressin function in the processing of information and possibly other aspects of affective illness.This publication has 4 references indexed in Scilit:
- VASOPRESSIN IN AFFECTIVE ILLNESSThe Lancet, 1978
- Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.Proceedings of the National Academy of Sciences of the United States of America, 1975
- Selective reminding for analysis of memory and learningJournal of Verbal Learning and Verbal Behavior, 1973
- Category norms of verbal items in 56 categories A replication and extension of the Connecticut category norms.Journal of Experimental Psychology, 1969